BACKGROUND: There are disputes whether inhaled corticosteroids (ICS) increase the
incidence of fracture or osteoporosis among patients with COPD. The aim of this meta …

The effect of inhaled corticosteroids (ICS) on the risk of osteoporosis and fracture in patients
with chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study …

Background The effect of inhaled corticosteroids (ICS) on fracture risk in patients with
chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study was …

Background It is uncertain whether long-term use of inhaled corticosteroids (ICSs), widely
used to treat COPD, increases the risk of fracture, particularly in women, in view of the …

Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD)
treated with inhaled corticosteroids is controversial. And some large-scale randomized …

Background Whether the use of inhaled corticosteroids (ICSs) in patients with COPD can
protect from osteoporosis remains undetermined. The aim of this study is to assess the …

Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …

Despite the widespread campaign to reduce the use of inhaled corticosteroids (ICSs) for
patients with COPD, ICS use is still highly prevalent in the community. In general, ICSs are …

PURPOSE: To assess the risk of non-vertebral fracture associated with inhaled
corticosteroid (ICS) use among older adults with diagnosed chronic obstructive pulmonary …